OMER Q2 2021 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$400,000

Operating Income

-$46M

Net Income

-$29M

EPS (Diluted)

$-0.46

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$145M

Total Liabilities

$392M

Stockholders' Equity

-$246M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$14M	-100.0%
Gross Profit	-$400,000	$13M	-103.0%
Operating Income	-$46M	-$28M	-64.8%
Net Income	-$29M	-$33M	+14.1%